223 related articles for article (PubMed ID: 12385578)
61. Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer.
Woo M; Park K; Nam J; Kim JC
J Gastroenterol Hepatol; 2007 Jul; 22(7):1064-70. PubMed ID: 17608852
[TBL] [Abstract][Full Text] [Related]
62. Plasminogen activator inhibitor 1 (PAI-1) 1334G/A genetic polymorphism in colorectal cancer.
Smolarz B; Romanowicz-Makowska H; Kulig A
Acta Biochim Pol; 2003; 50(2):489-95. PubMed ID: 12833173
[TBL] [Abstract][Full Text] [Related]
63. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with mortality in haemodialysis patients.
Cozzolino M; Biondi ML; Galassi A; Turri O; Brancaccio D; Gallieni M
Nephrol Dial Transplant; 2009 Jul; 24(7):2207-12. PubMed ID: 19221176
[TBL] [Abstract][Full Text] [Related]
64. Association of the 5A/6A promoter polymorphism of the MMP-3 gene with the radiographic progression of rheumatoid arthritis.
Nemec P; Pavkova-Goldbergova M; Gatterova J; Vasku A; Soucek M
Ann N Y Acad Sci; 2007 Sep; 1110():166-76. PubMed ID: 17911432
[TBL] [Abstract][Full Text] [Related]
65. Ser326Cys polymorphism in DNA repair genes hOGG1 in breast cancer women.
Romanowicz-Makowska H; Smolarz B; Makowski M; Połać I; Pertyński T
Pol J Pathol; 2008; 59(4):201-4. PubMed ID: 19391486
[TBL] [Abstract][Full Text] [Related]
66. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms.
Nanni S; Melandri G; Hanemaaijer R; Cervi V; Tomasi L; Altimari A; Van Lent N; Tricoci P; Bacchi L; Branzi A
Transl Res; 2007 Mar; 149(3):137-44. PubMed ID: 17320799
[TBL] [Abstract][Full Text] [Related]
67. Single nucleotide polymorphisms in MMP1 and MMP3 gene promoters as risk factor in head and neck squamous cell carcinoma.
Zinzindohoué F; Blons H; Hans S; Loriot MA; Houllier AM; Brasnu D; Laccourreye O; Tregouet DA; Stucker I; Laurent-Puig P
Anticancer Res; 2004; 24(3b):2021-6. PubMed ID: 15274394
[TBL] [Abstract][Full Text] [Related]
68. [Matrix metalloproteinase-3 genotype distribution and its relation with blood pressure profiles in Guangzhou rural population].
Shao Y; Deng M; Lian Z; Shi M; Jiang X
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Apr; 33(4):586-9. PubMed ID: 23644126
[TBL] [Abstract][Full Text] [Related]
69. Stromelysin promoter 5A/6A polymorphism is associated with acute myocardial infarction.
Terashima M; Akita H; Kanazawa K; Inoue N; Yamada S; Ito K; Matsuda Y; Takai E; Iwai C; Kurogane H; Yoshida Y; Yokoyama M
Circulation; 1999 Jun; 99(21):2717-9. PubMed ID: 10351963
[TBL] [Abstract][Full Text] [Related]
70. Matrix metalloproteinase-3 gene polymorphism and dilatative pathology of ascending thoracic aorta.
Lesauskaite V; Sinkūnaite G; Benetis R; Grabauskas V; Vaskelyte J; Smalinskiene A; Simonyte S; Jariene G; Tatarūnas V; Klumbiene J; Petkeviciene J; Kinduris S; Giedraitis S; Sakalauskas J; Bolys R; Sirvinskas E; Lenkutis T; Pangonyte D
Medicina (Kaunas); 2008; 44(5):386-91. PubMed ID: 18541955
[TBL] [Abstract][Full Text] [Related]
71. [Association of matrix metalloproteinase-3 serum level and the promoter 5A/6A polymorphism of the MMP-3 gene with atherosclerotic cerebral infarction].
Huang X; Zhu M; Jin X; Zhang D; Wang L; Ye Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Dec; 25(6):653-6. PubMed ID: 19065524
[TBL] [Abstract][Full Text] [Related]
72. Matrix metalloproteinase-3 and intracranial arterial dolichoectasia.
Pico F; Jacob MP; Labreuche J; Soufir N; Touboul PJ; Benessiano J; Cambien F; Grandchamp B; Michel JB; Amarenco P
Ann Neurol; 2010 Apr; 67(4):508-15. PubMed ID: 20437586
[TBL] [Abstract][Full Text] [Related]
73. Matrix Metalloproteinase 3 Gene Polymorphism and Its Level Predict Morbidity After Acute Myocardial Infarction.
Abd El-Aziz TA; Mohamed RH
Am J Clin Pathol; 2016 Jan; 145(1):134-9. PubMed ID: 26712881
[TBL] [Abstract][Full Text] [Related]
74. Analysis of two polymorphisms in the promoter region of matrix metalloproteinase 1 and 3 genes in women with endometriosis.
Ferrari MM; Biondi ML; Rossi G; Grijuela B; Gaita S; Perugino G; Viganò P
Acta Obstet Gynecol Scand; 2006; 85(2):212-7. PubMed ID: 16532917
[TBL] [Abstract][Full Text] [Related]
75. Impact of 5A/6A polymorphism of matrix metalloproteinase-3 on recurrent atherosclerotic ischemic stroke in Chinese.
Huang XY; Han LY; Huang XD; Guan CH; Mao XL; Ye ZS
Int J Neurosci; 2016 Oct; 126(10):936-41. PubMed ID: 26314579
[TBL] [Abstract][Full Text] [Related]
76. Polymorphism of matrix metalloproteinase-3 promoter gene as a risk factor for coronary artery lesions in Kawasaki disease.
Park JA; Shin KS; Kim YW
J Korean Med Sci; 2005 Aug; 20(4):607-11. PubMed ID: 16100452
[TBL] [Abstract][Full Text] [Related]
77. Heterozygosity of stromelysin-1 (rs3025058) promoter polymorphism is associated with gastric cancer.
Krishnaveni D; Bhayal AC; Shravan KP; Jyothy A; Pratibha N; Venkateshwari A
Indian J Cancer; 2015; 52(2):251-4. PubMed ID: 26853425
[TBL] [Abstract][Full Text] [Related]
78. [Assessment of the role of matrix metalloproteinase-3 gene polymorphism in the development of chronic heart failure].
Teplyakov AT; Berezikova EN; Shilov SN; Grakova EV; Torim YY; Efremov AV; Safronov ID; Pustovetova MG; Karpov RS
Ter Arkh; 2015; 87(4):8-12. PubMed ID: 26087627
[TBL] [Abstract][Full Text] [Related]
79. Genetic variation in human stromelysin gene promoter and common carotid geometry in healthy male subjects.
Gnasso A; Motti C; Irace C; Carallo C; Liberatoscioli L; Bernardini S; Massoud R; Mattioli PL; Federici G; Cortese C
Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1600-5. PubMed ID: 10845878
[TBL] [Abstract][Full Text] [Related]
80. Matrix metalloproteinase-1 and matrix metalloproteinase-3 gene promoter polymorphisms are associated with carotid artery stenosis.
Ghilardi G; Biondi ML; DeMonti M; Turri O; Guagnellini E; Scorza R
Stroke; 2002 Oct; 33(10):2408-12. PubMed ID: 12364729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
